IMPORTANT INFORMATION

Access to the information and documents on this portion of the website is restricted for regulatory reasons. You are requested to review the following information and make the following confirmation each time you seek to access this restricted information. Your confirmation must be true and accurate.

Please enter your country of residence:

IMPORTANT INFORMATION

ACCESS TO THE INFORMATION AND DOCUMENTS ON THIS PORTION OF THE WEBSITE IS RESTRICTED FOR REGULATORY REASONS. YOU ARE REQUESTED TO REVIEW THE FOLLOWING INFORMATION AND MAKE THE FOLLOWING CONFIRMATION EACH TIME YOU SEEK TO ACCESS THIS RESTRICTED INFORMATION. YOUR CONFIRMATION MUST BE TRUE AND ACCURATE.

ELECTRONIC VERSIONS OF THE MATERIALS YOU ARE SEEKING TO ACCESS ARE BEING MADE AVAILABLE ON THIS WEBSITE BY DARKTRACE PLC (THE "ISSUER") IN GOOD FAITH AND ARE FOR INFORMATION PURPOSES ONLY. THE ISSUER DOES NOT ACCEPT ANY RESPONSIBILITY FOR ANY CONTRAVENTION OF APPLICABLE SECURITIES LAWS AND REGULATIONS BY INDIVIDUALS FOR THE ACCURACY, COMPLETENESS OR FAIRNESS OR USE OF INFORMATION PROVIDED BY SUCH INDIVIDUALS.

THESE MATERIALS ARE NOT DIRECTED AT OR ACCESSIBLE BY PERSONS IN THE UNITED STATES OR PERSONS RESIDENT OR LOCATED IN AUSTRALIA, CANADA, DUBAI, HONG KONG, JAPAN, SINGAPORE, SWITZERLAND OR ANY OTHER JURISDICTION WHERE THE EXTENSION OF AVAILABILITY OF THE MATERIALS TO WHICH YOU ARE SEEKING ACCESS WOULD BREACH ANY APPLICABLE LAW OR REGULATION.

The release, publication or distribution of the documents or other information contained herein may be restricted by law in certain jurisdictions. Persons into whose possession any of the documents or other information contained herein come should inform themselves about and observe any such restrictions. Any failure to comply with any such restrictions may constitute a violation of the securities laws or regulations of such jurisdiction.

The information and documents on this portion of the website (a) are intended only for, and may be accessed by, or distributed or disseminated, directly or indirectly, in whole or in part, to (i) "qualified institutional buyers" (as defined in Rule 144A under the U.S. Securities Act of 1933, as amended (the "US Securities Act") ("QIBs") or (ii) persons resident or physically present outside the United States (including its territories and possessions, any state of the United States and the District of Columbia), Australia, Canada, Dubai, Hong Kong, Japan, Singapore, Switzerland and resident and physically present in a jurisdiction in which such access, distribution or dissemination would not constitute a violation of the local securities laws or regulations of such jurisdiction, and (b) are not and do not constitute an offer to sell or the solicitation of an offer to buy or acquire, any ordinary shares or other securities of the Issuer in the United States, Australia, Canada, Dubai, Hong Kong, Japan, Singapore, Switzerland or any other jurisdiction in which such offer or solicitation would constitute a violation of the local securities laws or regulations of such jurisdiction or would be otherwise unlawful.

Securities may not be sold in the United States absent registration with the United States Securities and Exchange Commission or an exemption from registration under the US Securities Act. In particular, the securities have not been and will not be registered under the US Securities Act, and may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the US Securities Act. Any securities will not be registered under or offered in compliance with applicable securities laws of any state, province, territory, county or jurisdiction of the United States, Canada, Dubai, Hong Kong, Japan, Singapore or Switzerland. Accordingly, unless an exemption under the relevant securities law is applicable, any such securities may not be offered, sold, resold, delivered or distributed, directly or indirectly, in or into the United States, Canada, Dubai, Hong Kong, Japan, Singapore, Switzerland or any other jurisdiction if to do so would constitute a violation of the relevant laws of, or require registration thereof in, such jurisdiction. There will be no public offering of securities in the United States. Any securities sold in the United States will be sold only to QIBs in reliance on an exemption from, or transaction not subject to, the registration requirements of the US Securities Act.

The information and documents on this portion of the website are being addressed to and directed at persons in member states of the European Economic Area ("Member States") who are "qualified investors" within the meaning of Article 2(e) of the Prospectus Regulation (Regulation (EU) 2017/1129) ("Qualified Investors"). In addition, in the United Kingdom, this document is being distributed only to, and is directed only at, "qualified investors" within the meaning of Article 2(e) of the Prospectus Regulation (Regulation (EU) 2017/1129), as amended by The Prospectus (Amendment etc.) (EU Exit) Regulations 2019, and which is part of UK law by virtue of the European Union (Withdrawal) Act 2018 who are also persons who have professional experience in matters relating to investments falling within the definition of "investment professionals" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 as amended (the "Order") or who are high net worth bodies corporate, unincorporated associations and partnerships or the trustee of high value trusts falling within Article 49(2)(a) to (d) of the Order, and other persons to whom it may otherwise lawfully be communicated (all such persons together being referred to as "Relevant Persons"). Any investment or investment activity to which this document relates is available only to Relevant Persons in the United Kingdom and Qualified Investors in Member States, and will only be engaged with such persons. Persons who are not Relevant Persons (in the United Kingdom) or Qualified Investors (in Member States) should not act or rely on this document or any of its contents..

Certain statements contained in documents available on this part of the website constitute forward-looking statements. By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties and assumptions could adversely affect the outcome and financial effects of the plans and events described herein. Forward-looking statements contained in documents available on this part of the website that reference past trends or activities should not be taken as a representation that such trends or activities will necessarily continue in the future. You should not place undue reliance on forward-looking statements, which speak only as of the date of the relevant document.

To confirm that:

you have read, understand and agree to comply with all of the restrictions set forth above;
you are either (i) a QIB in the United States or (ii) are resident and physically present in a country outside the United States, Canada, Dubai, Hong Kong, Japan, Singapore or Switzerland or any other jurisdiction in which such distribution or access is unlawful;
you are not resident or physically present in any Member State, unless you are a Qualified Investor;
you are not resident or physically present in the United Kingdom, unless you are a Relevant Person;
it is lawful for you to review and receive copies of the documents on this website;
you agree that you will not transmit or otherwise send any information contained in this website to any person in the United States or to publications with a general circulation in the United States; and
are authorised and permitted to proceed to electronic versions of the information and documents on this portion of the website.

Please select "I confirm" below:

DISCLAIMER – IMPORTANT

We regret that, due to applicable legal restrictions, we are unable to provide you with access to this section of our website.

We apologise for any inconvenience this may cause.

Click here to return to the homepage.

Regulatory News

Form 8.3 - Darktrace plc

RNS Number : 9704Y

Societe Generale SA

09 September 2022

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

1. KEY INFORMATION

(a) Full name of discloser:	Société Générale S.A.
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree	Darktrace plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure	08/09/2022
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state "N/A"	NO

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:	Ordinary
	Interests		Short positions
	Number	%	Number	%
(1) Relevant securities owned and/or controlled:	6,061,036	0.84	7,459	0.00
(2) Cash-settled derivatives:	4,985,322	0.69	28,348	0.00
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:	0	0.00	0	0.00
TOTAL:	11,046,358	1.54	35,807	0.00

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors' and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security	Purchase/sale	Number of securities	Price per unit GBP
Ordinary	Purchase	181,059	3.5294743
Ordinary	Purchase	25	3.564
Ordinary	Purchase	26	3.564
Ordinary	Purchase	180	3.564
Ordinary	Purchase	4,000	3.634
Ordinary	Purchase	6	3.584
Ordinary	Purchase	66	3.6
Ordinary	Purchase	540	3.564
Ordinary	Purchase	444	3.564
Ordinary	Purchase	377	3.564
Ordinary	Purchase	352	3.564
Ordinary	Purchase	120	3.599
Ordinary	Purchase	750	3.6
Ordinary	Purchase	507	3.598
Ordinary	Purchase	190	3.6
Ordinary	Purchase	173	3.598
Ordinary	Purchase	36	3.564
Ordinary	Purchase	20	3.564
Ordinary	Purchase	171	3.598
Ordinary	Purchase	17	3.6
Ordinary	Purchase	2,406	3.41
Ordinary	Purchase	1,649	3.41
Ordinary	Purchase	1,669	3.4
Ordinary	Purchase	285	3.683
Ordinary	Purchase	286	3.4
Ordinary	Purchase	1,093	3.41
Ordinary	Purchase	124	3.4
Ordinary	Purchase	87	3.415
Ordinary	Purchase	188	3.4
Ordinary	Purchase	145	3.371
Ordinary	Purchase	1,851	3.36
Ordinary	Purchase	205	3.42
Ordinary	Purchase	240	3.438
Ordinary	Purchase	154	3.4
Ordinary	Purchase	345	3.479
Ordinary	Purchase	2,501	3.475
Ordinary	Purchase	1,714	3.581
Ordinary	Purchase	98	3.432
Ordinary	Purchase	140	3.409
Ordinary	Purchase	18,941	3.513742
Ordinary	Sale	921	3.398
Ordinary	Sale	801	3.388
Ordinary	Sale	1,664	3.574
Ordinary	Sale	2,127	3.434
Ordinary	Sale	1,000	3.414
Ordinary	Sale	631	3.355
Ordinary	Sale	496	3.403
Ordinary	Sale	29	3.402
Ordinary	Sale	870	3.393
Ordinary	Sale	1,013	3.43
Ordinary	Sale	27	3.355
Ordinary	Sale	254	3.351
Ordinary	Sale	512	3.351
Ordinary	Sale	1,000	3.477
Ordinary	Sale	157	3.403
Ordinary	Sale	107	3.403
Ordinary	Sale	218	3.391
Ordinary	Sale	71	3.391
Ordinary	Sale	605	3.391
Ordinary	Sale	715	3.35
Ordinary	Sale	704	3.353
Ordinary	Sale	758	3.454
Ordinary	Sale	15	3.455
Ordinary	Sale	165,000	3.456793
Ordinary	Sale	240,600	3.6284742
Ordinary	Sale	20,000	3.443622
Ordinary	Sale	134	3.549
Ordinary	Sale	1,748	3.62
Ordinary	Sale	678	3.643
Ordinary	Sale	259	3.483
Ordinary	Sale	500	3.483
Ordinary	Sale	923	3.643
Ordinary	Sale	723	3.643
Ordinary	Sale	450	3.643
Ordinary	Sale	503	3.643
Ordinary	Sale	723	3.643
Ordinary	Sale	1,107	3.47
Ordinary	Sale	252	3.62
	Total Purchases	223,180
	Total Sales	448,295

(b) Cash-settled derivative transactions

Class of relevant security	Product description e.g. CFD	Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position	Number of reference securities	Price per unit GBP
Ordinary	CFD	Reducing a long position	18,941	3.52947432
Ordinary	CFD	Reducing a long position	161,059	3.52947432
Ordinary	CFD	Increasing a short position	1,059	3.52947432
Ordinary	CFD	Increasing a short position	2,000	3.60776025
Ordinary	CFD	Increasing a short position	2,000	3.60776025
Ordinary	CFD	Increasing a short position	4,000	3.60776025
Ordinary	CFD	Increasing a short position	18,941	3.513742
Ordinary	CFD	Reducing a short position	98,862	3.62847415
Ordinary	CFD	Reducing a short position	92,968	3.62847415
Ordinary	CFD	Reducing a short position	67,799	3.456793
Ordinary	CFD	Reducing a short position	63,756	3.456793
Ordinary	CFD	Reducing a short position	42,105	3.62847415
Ordinary	CFD	Reducing a short position	28,875	3.456793
Ordinary	CFD	Reducing a short position	8,218	3.443622
Ordinary	CFD	Reducing a short position	7,728	3.443622
Ordinary	CFD	Reducing a short position	6,665	3.62847415
Ordinary	CFD	Reducing a short position	6,000	3.596556625
Ordinary	CFD	Reducing a short position	4,570	3.456793
Ordinary	CFD	Reducing a short position	3,500	3.443622
Ordinary	CFD	Reducing a short position	2,000	3.596556625
Ordinary	CFD	Reducing a short position	554	3.443622

(i) Writing, selling, purchasing, or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

GBP

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit GBP

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable) GBP

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

Is a Supplemental Form 8 (Open Positions) attached?

Date of disclosure:	09/09/2022
Contact name:	Paul Jenkins
Telephone number*:	+44 20 7676 6969

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RETSSEFFUEESEEU

Form 8.3 - DARKTRACE PLC ›

Director/PDMR Shareholding ›

Back to:

Back to Regulatory News ⌃

Form 8.3 - Darktrace plc

FORM 8.3

Date of disclosure:

Contact name:

Telephone number*:

Products

Core Coverage

AI Research Centre

Company

Partners

Legal

Products

Core Coverage

AI Research Centre

Company

Partners

Legal

Products

Core Coverage

AI Research Centre

Company

Partners

Legal